SOUTHLAKE, Texas, Dec. 9, 2015 /PRNewswire/ -- Niche Pharmaceuticals, Inc. has launched a microsite (www.MagnesiumRoadtoMigrainePrevention.com) which features an overview of the research done on the link between magnesium deficiency and chronic migraine headaches. Niche Pharmaceuticals invites people with chronic migraine headaches to explore the site to better understand findings on the connection between low magnesium and migraine headaches.
Published clinical trials (1) have shown that daily magnesium supplementation taken for a minimum of two to three months can reduce the occurrence of migraine days by at least fifty percent. Results will vary per individual. In fact, the American Headache Society and the American Academy of Neurology now include oral magnesium in their preventive treatment guidelines for migraines (2). There is strong evidence that magnesium deficiency is much more prevalent in those with chronic migraine headaches than in healthy controls.
Mag-Tab®SR is Niche's magnesium product that has a unique formulation that delivers magnesium L-lactate dihydrate into the body slowly for maximum absorption. Taken daily, Mag-Tab®SR provides twenty-four hours of continuous magnesium supplementation. The slow release component leads to better uptake in the body's cells and relief of many symptoms associated with magnesium deficiency.
According to the company's founder and CEO, Steve F. Brandon, studies show(3) approximately four out of five people in the United States do not get enough magnesium in their diet and may be magnesium deficient. Up to fifty percent of the thirty-six million American migraine sufferers have low magnesium levels associated with their chronic migraines (4). This is especially true for women (5). Doctors recommend non-prescription Mag-Tab®SR because it is a sustained release magnesium supplement that is highly absorbed and well-tolerated by the gastrointestinal tract(6).
A "Migraine Prevention" pack with two bottles of one hundred caplets and a free sixty count bottle are available as part of the campaign and can be purchased at http://www.magnesiumroadtomigraineprevention.com. The pack contains two months' worth of daily magnesium intake and participants will receive a discount code for their next purchase at magtabsr.com, the company's website. Migraineurs are invited to share their progress and results on Mag-Tab® SR's Facebook page (www.facebook.com/magtabsr), tweet to @magtabsr, and use the mobile migraine tracking app Migraine Buddy where a Mag-Tab®SR group has been created.
About Niche Pharmaceuticals, Inc.
Niche Pharmaceuticals, Inc. was founded in 1991 to develop and market ethical pharmaceutical grade nutraceutical products that fulfill unmet medical needs. Over the years, Niche has a developed a reputable base of U.S. and International doctors who recommend Mag-Tab®SR, a non-prescription magnesium supplement. Niche has also dedicated considerable financial resources towards developing the first Rx oral magnesium product for the prevention of migraine headaches with major clinical trials now underway across the US.
Niche Pharmaceuticals, Inc.
580 Commerce St, Ste. 100
Southlake, Texas 76092
SOURCE Niche Pharmaceuticals, Inc.